+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lutetium-177 Market - Global Forecast 2026-2032- Product Image
Lutetium-177 Market - Global Forecast 2026-2032- Product Image
Sale

Lutetium-177 Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5997366
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lutetium-177 Market is projected to reach USD 1.23 Billion in 2026. It is expected to continue growing at a CAGR of 16.76%, reaching USD 3.13 Billion by 2032.

Lutetium-177: Executive Summary of a Radiopharmaceutical Modality

Lutetium-177 is a therapeutic radioisotope used in targeted radioligand therapies, where a radioactive payload is linked to a molecule designed to bind selected tumor markers. Its clinical relevance is shaped by patient selection, diagnostic imaging, isotope quality, radiochemistry, manufacturing capacity, radiation safety, and treatment-center readiness. The field is moving from specialized applications toward broader integration with precision oncology, while evidence generation and operational execution remain central to adoption.

Clinical Integration and Supply-Chain Resilience Are Reshaping Lutetium-177

The landscape is being transformed by the convergence of companion imaging, biomarker-defined treatment pathways, and more standardized radiopharmaceutical production. Hospitals and developers must coordinate isotope procurement, ligand synthesis, quality control, dispensing, administration, and post-treatment monitoring within strict time and radiation-safety constraints. Regulatory expectations, radioactive-material transport requirements, workforce availability, and the need for geographically accessible treatment centers are also influencing how quickly programs can be implemented. As clinical evidence expands, multidisciplinary collaboration among nuclear medicine, medical oncology, radiopharmacy, physics, and logistics teams is becoming increasingly important.

Artificial Intelligence Supports Selection, Imaging, Operations, and Evidence Generation

Artificial intelligence can strengthen Lutetium-177 programs by assisting image interpretation, lesion detection, dosimetry, response assessment, and identification of patients most likely to benefit from targeted therapy. Predictive models may also help optimize treatment scheduling, monitor toxicity, forecast isotope and radiopharmacy needs, and detect deviations in manufacturing or delivery workflows. These applications require representative data, clinically validated endpoints, transparent model performance, and safeguards against bias. AI should support-not replace-physician judgment, multidisciplinary review, radiological protection procedures, and regulatory compliance.

Regional Readiness Varies Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America combines established nuclear medicine capabilities with active clinical development and specialized treatment infrastructure, although access can vary by jurisdiction and facility. Europe benefits from sophisticated radiopharmacy networks and coordinated clinical expertise, while differing national reimbursement, licensing, and transport systems affect implementation. Asia-Pacific includes advanced centers with strong nuclear medicine traditions alongside markets where infrastructure, trained personnel, and isotope logistics remain uneven. The Middle East is expanding specialized healthcare capacity, but availability is concentrated in major hubs. Latin America and Africa face greater variation in isotope access, treatment-center density, regulatory resources, and specialist training, making partnerships and referral networks important for equitable delivery.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Reflect Different Deployment Priorities

ASEAN countries are likely to emphasize regional referral pathways, workforce development, and shared radiopharmacy capabilities as access expands. BRICS members encompass substantial scientific and clinical capacity but differ considerably in regulation, infrastructure, domestic production, and affordability. The European Union benefits from cross-border scientific collaboration while retaining national differences in reimbursement and healthcare delivery. G7 members generally have mature oncology and nuclear medicine ecosystems, with priorities centered on evidence, safety, supply resilience, and integration into routine care. GCC states are investing in advanced healthcare hubs and may use centralized expertise to support regional access. NATO members span diverse health systems, making coordination on critical supply chains, emergency preparedness, and specialist capabilities relevant to radiopharmaceutical resilience.

Country-Level Conditions Shape Clinical Access and Radiopharmaceutical Execution

Australia and Canada must address geographic dispersion and specialized workforce requirements alongside strong clinical governance. Brazil and Mexico face the operational challenge of extending advanced radiopharmaceutical services beyond major urban centers. China and India combine significant healthcare demand with expanding research, manufacturing, and treatment capabilities, while regional variation remains material. France, Germany, Italy, Spain, and the United Kingdom have established nuclear medicine expertise, but national approval, reimbursement, procurement, and capacity pathways differ. Japan and South Korea offer advanced oncology and imaging infrastructure with distinct regulatory and demographic considerations. Russia’s capabilities are influenced by domestic infrastructure, supply arrangements, and access to specialized technology. In the United States, sophisticated academic and clinical networks coexist with complex logistics, site-readiness, and coverage requirements.

Industry Leaders Should Build Integrated, Evidence-Driven Lutetium-177 Programs

Leaders should align clinical evidence with clearly defined patient pathways, validated diagnostic selection, dosimetry practices, and long-term safety monitoring. They should diversify isotope and precursor sourcing, qualify backup logistics routes, and establish robust quality systems for radiochemistry and release testing. Partnerships with hospitals, radiopharmacies, imaging providers, regulators, and training institutions can expand operational readiness. Investment in workforce development should cover nuclear medicine physicians, medical physicists, radiopharmacists, technologists, nurses, and radiation-safety personnel. Organizations should also deploy AI selectively, beginning with high-value, auditable use cases and maintaining human oversight. Access planning should include referral coordination, transparent eligibility criteria, affordability considerations, and infrastructure support for under-served regions.

Methodology: Triangulating Clinical, Regulatory, Operational, and Geographic Evidence

This executive summary applies a structured qualitative synthesis focused on Lutetium-177 as a targeted radiopharmaceutical modality. The assessment considers peer-reviewed clinical literature, regulatory and safety frameworks, treatment-pathway requirements, radiopharmacy and isotope-supply principles, healthcare infrastructure, and regional implementation conditions. Insights are organized across clinical development, manufacturing, logistics, workforce, access, and technology adoption. Regional, group, and country observations are framed as contextual comparisons rather than quantitative market measurements. No market estimates, market shares, forecasts, or company-specific claims are used.

Lutetium-177’s Progress Depends on Coordinated Science, Infrastructure, and Access

Lutetium-177 is positioned at the intersection of precision oncology, nuclear medicine, radiopharmacy, and complex healthcare logistics. Continued clinical validation, dependable isotope handling, trained multidisciplinary teams, responsible use of AI, and fit-for-purpose regulation will determine how effectively its therapeutic applications reach patients. The strongest programs will connect diagnosis, treatment, safety monitoring, manufacturing, and referral infrastructure into a single coordinated pathway. Regional collaboration and equitable access planning will be essential as healthcare systems seek to translate radioligand therapy advances into reliable clinical practice.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Lutetium-177 Market, by Product Type
7.1. Introduction
7.2. Carrier-Added Lutetium-177
7.3. No-Carrier-Added Lutetium-177
8. Lutetium-177 Market, by Production Technology
8.1. Introduction
8.2. Cyclotron-Based Production
8.3. Reactor-Based Production
9. Lutetium-177 Market, by Application
9.1. Introduction
9.2. Research & Preclinical
9.2.1. In Vitro Studies
9.2.2. In Vivo Animal Models
9.3. Therapeutics
9.3.1. Hematologic Malignancies
9.3.2. Neuroendocrine Tumors (SSTR)
9.3.3. Palliative Bone Metastases
9.3.4. Prostate Cancer (PSMA)
10. Lutetium-177 Market, by End-User
10.1. Introduction
10.2. Hospitals
10.3. Outpatient Centers
10.4. Pharmaceutical and Biotechnology Companies
10.5. Research Institutions
10.6. Specialty Clinics
11. Lutetium-177 Market, by Distribution Channel
11.1. Introduction
11.2. Direct Purchase
11.3. Indirect
12. Lutetium-177 Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Africa
12.6. Latin America
12.7. Middle East
13. Lutetium-177 Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. European Union
13.5. BRICS
13.6. ASEAN
13.7. GCC
14. Lutetium-177 Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. Japan
14.6. India
14.7. United Kingdom
14.8. France
14.9. Canada
14.10. Australia
14.11. Italy
14.12. Brazil
14.13. South Korea
14.14. Russia
14.15. Mexico
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Actinium Pharmaceuticals, Inc.
16.2. Bayer AG
16.3. BWX Technologies, Inc.
16.4. Cardinal Health, Inc.
16.5. China National Nuclear Corporation
16.6. Curium Pharma
16.7. Eckert & Ziegler Radiopharma GmbH
16.8. Framatome
16.9. Fusion Pharmaceuticals Inc. by AstraZeneca
16.10. IBA Radiopharma Solutions
16.11. Isotopia Molecular Imaging Ltd.
16.12. ITM Isotope Technologies Munich SE
16.13. Lantheus Holdings, Inc.
16.14. NorthStar Medical Radioisotopes, LLC
16.15. Novartis AG
16.16. NTP Radioisotopes SOC Ltd.
16.17. Nuclear Research and Consultancy Group
16.18. RadioMedix, Inc.
16.19. RayzeBio, Inc. by Bristol Myers Squibb
16.20. Revvity Inc.
16.21. SHINE Technologies, LLC
16.22. Telix Pharmaceuticals Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Lutetium-177 Market, Years Considered for the Study
FIGURE 2. Global Lutetium-177 Market, Research Design
FIGURE 3. Global Lutetium-177 Market, Research Framework
FIGURE 4. Global Lutetium-177 Market, Data Triangulation
FIGURE 5. Global Lutetium-177 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Lutetium-177 Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Lutetium-177 Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Lutetium-177 Market Size, by Production Technology, 2025 vs 2032 (%)
FIGURE 9. Global Lutetium-177 Market Size, by Production Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Lutetium-177 Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Lutetium-177 Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Lutetium-177 Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Lutetium-177 Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Lutetium-177 Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Lutetium-177 Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Lutetium-177 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Lutetium-177 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Lutetium-177 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Lutetium-177 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Lutetium-177 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Lutetium-177 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Lutetium-177 Market Segmentation & Coverage
TABLE 2. Global Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 3. Global Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Carrier-Added Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Carrier-Added Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Carrier-Added Lutetium-177 Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global No-Carrier-Added Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global No-Carrier-Added Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global No-Carrier-Added Lutetium-177 Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 11. Global Cyclotron-Based Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Cyclotron-Based Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Cyclotron-Based Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Reactor-Based Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Reactor-Based Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Reactor-Based Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 18. Global Research & Preclinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Research & Preclinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Research & Preclinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global In Vitro Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global In Vitro Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global In Vitro Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global In Vivo Animal Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global In Vivo Animal Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global In Vivo Animal Models Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Hematologic Malignancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Hematologic Malignancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Hematologic Malignancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Neuroendocrine Tumors (SSTR) Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Neuroendocrine Tumors (SSTR) Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Neuroendocrine Tumors (SSTR) Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Palliative Bone Metastases Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Palliative Bone Metastases Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Palliative Bone Metastases Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Prostate Cancer (PSMA) Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Prostate Cancer (PSMA) Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Prostate Cancer (PSMA) Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 43. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Outpatient Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Outpatient Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Outpatient Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pharmaceutical and Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Pharmaceutical and Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Pharmaceutical and Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 59. Global Direct Purchase Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Direct Purchase Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Direct Purchase Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Indirect Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Indirect Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Indirect Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Europe Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Europe Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Europe Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 77. Europe Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Europe Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 79. Europe Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 80. Europe Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 81. Europe Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. North America Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. North America Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. North America Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 85. North America Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. North America Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 87. North America Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 88. North America Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 89. North America Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Africa Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Africa Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Africa Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 93. Africa Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Africa Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 95. Africa Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 96. Africa Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 97. Africa Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Latin America Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Latin America Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Latin America Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 101. Latin America Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. Latin America Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 103. Latin America Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 104. Latin America Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 105. Latin America Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Middle East Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Middle East Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Middle East Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 109. Middle East Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Middle East Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 111. Middle East Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 112. Middle East Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 113. Middle East Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Global Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. NATO Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. NATO Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 118. NATO Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. NATO Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 120. NATO Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 121. NATO Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 122. NATO Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. G7 Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. G7 Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. G7 Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 126. G7 Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. G7 Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 128. G7 Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 129. G7 Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 130. G7 Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. European Union Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. European Union Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. European Union Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 134. European Union Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. European Union Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 136. European Union Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 137. European Union Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 138. European Union Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. BRICS Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. BRICS Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. BRICS Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 142. BRICS Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. BRICS Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 144. BRICS Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 145. BRICS Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 146. BRICS Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. ASEAN Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. ASEAN Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. ASEAN Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 150. ASEAN Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. ASEAN Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 152. ASEAN Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 153. ASEAN Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 154. ASEAN Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. GCC Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. GCC Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. GCC Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 158. GCC Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. GCC Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 160. GCC Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 161. GCC Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 162. GCC Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Global Lutetium-177 Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. United States Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 165. United States Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. United States Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 167. United States Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. United States Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 169. United States Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 170. United States Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 171. United States Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. China Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 173. China Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. China Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 175. China Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. China Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 177. China Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 178. China Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 179. China Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Germany Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 181. Germany Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Germany Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 183. Germany Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Germany Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 185. Germany Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 186. Germany Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. Germany Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Japan Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 189. Japan Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Japan Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 191. Japan Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Japan Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 193. Japan Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 194. Japan Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 195. Japan Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. India Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 197. India Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. India Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 199. India Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. India Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 201. India Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 202. India Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 203. India Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. United Kingdom Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 205. United Kingdom Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. United Kingdom Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 207. United Kingdom Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. United Kingdom Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 209. United Kingdom Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 210. United Kingdom Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 211. United Kingdom Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. France Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 213. France Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. France Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 215. France Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. France Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 217. France Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 218. France Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 219. France Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Canada Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 221. Canada Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Canada Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 223. Canada Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Canada Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 225. Canada Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 226. Canada Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 227. Canada Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Australia Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 229. Australia Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Australia Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 231. Australia Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Australia Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 233. Australia Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 234. Australia Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 235. Australia Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Italy Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 237. Italy Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Italy Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 239. Italy Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Italy Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 241. Italy Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 242. Italy Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 243. Italy Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Brazil Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 245. Brazil Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. Brazil Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 247. Brazil Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. Brazil Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 249. Brazil Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 250. Brazil Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 251. Brazil Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. South Korea Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 253. South Korea Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. South Korea Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 255. South Korea Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. South Korea Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 257. South Korea Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 258. South Korea Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 259. South Korea Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Russia Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 261. Russia Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. Russia Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 263. Russia Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. Russia Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 265. Russia Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 266. Russia Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 267. Russia Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Mexico Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 269. Mexico Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Mexico Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 271. Mexico Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. Mexico Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 273. Mexico Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 274. Mexico Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 275. Mexico Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. Spain Lutetium-177 Market Size, 2017-2032 (USD Million)
TABLE 277. Spain Lutetium-177 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Spain Lutetium-177 Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 279. Spain Lutetium-177 Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Spain Lutetium-177 Market Size, by Research & Preclinical, 2017-2032 (USD Million)
TABLE 281. Spain Lutetium-177 Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 282. Spain Lutetium-177 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 283. Spain Lutetium-177 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Global Lutetium-177 Market Share, by Key Player, 2025
TABLE 285. Global Lutetium-177 Market, Key Experts

Companies Mentioned

  • Actinium Pharmaceuticals, Inc.
  • Bayer AG
  • BWX Technologies, Inc.
  • Cardinal Health, Inc.
  • China National Nuclear Corporation
  • Curium Pharma
  • Eckert & Ziegler Radiopharma GmbH
  • Framatome
  • Fusion Pharmaceuticals Inc. by AstraZeneca
  • IBA Radiopharma Solutions
  • Isotopia Molecular Imaging Ltd.
  • ITM Isotope Technologies Munich SE
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • Nuclear Research and Consultancy Group
  • RadioMedix, Inc.
  • RayzeBio, Inc. by Bristol Myers Squibb
  • Revvity Inc.
  • SHINE Technologies, LLC
  • Telix Pharmaceuticals Limited

Related Topics

Related Reports

Lutetium-177 Supply Market Global Report 2026 - Product Image

Lutetium-177 Supply Market Global Report 2026

  • Report
  • 250 Pages
  • Global
From
Radioligand Therapy (RLT) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Radioligand Therapy (RLT) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Targeted SSTR Radionuclide Drug Conjugates Market - Global Forecast 2026-2032 - Product Image

Targeted SSTR Radionuclide Drug Conjugates Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Lutetium-177 (CAS 14265-75-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Lutetium-177 (CAS 14265-75-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Peptide-Radionuclide Conjugates Market - Global Forecast 2026-2032 - Product Image

Peptide-Radionuclide Conjugates Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.